Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease
- 1 June 1993
- journal article
- review article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 91 (2-3) , 255-269
- https://doi.org/10.1007/bf01245235
Abstract
Current antiparkinsonian therapies focus on either replacing dopamine via precursor (L-DOPA) administration, or directly stimulating postsynaptic dopamine receptors with dopamine agonists. Unfortunately, this approach is associated with numerous side effects and these drugs lose efficacy with disease progression. This article reviews recent evidence which suggests that negative modulation of glutamatergic neurotransmission has antiparkinsonian effects in a variety of rodent and primate models of parkinsonism. The pronounced synergism between dopaminergic agents and glutamate receptor antagonists may provide a means of using very low doses of the two drug classes in concert to treat Parkinson's disease effectively and minimize dose-related drug side effects.Keywords
This publication has 45 references indexed in Scilit:
- Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's diseaseTrends in Neurosciences, 1990
- Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological dataBrain Research, 1990
- Prolonged changes in plasma concentrations of catecholamine metabolites following a single infusion of an MPTP analogLife Sciences, 1990
- Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonismLife Sciences, 1990
- Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkeyNeuropharmacology, 1989
- Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted miceJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- The functional anatomy of basal ganglia disordersTrends in Neurosciences, 1989
- Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) on catecholamines in heart, adrenal gland, retina and caudate nucleus of the catToxicology Letters, 1988
- Practical Therapy of Parkinson's DiseaseSeminars in Neurology, 1987
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986